Multiple studies have indicated that high expression of PD-L1 in chordoma tissues and PD-L1-positive tumors are significantly related to advanced chordoma and the prevalence of TILs [46,47,48], and ICIs targeting PD-L1 have shown obvious clinical activities against advanced chordoma [49]. The gene discussed is CD274; the disease is chordoma.